Interest of the serratus block in the management of acute pain during pleural drainage in polyvalent resuscitation.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2018-001621-47-FR

Enrollment

Registered

2018-11-29

Start date

2019-02-18

Completion date

Unknown

Last updated

2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pain during pleural drainage in polyvalent resuscitation

Interventions

Trade Name: LIDOCAÏNE ACCORD Pharmaceutical Form: Injection Trade Name: NAROPEINE 2 mg/ml Pharmaceutical Form: Injection Trade Name: NAROPEINE 7,5 mg/ml Pharmaceutical Form: Injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 70 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactProject Manager

CHU AMIENS-PICARDIE

Mattoug.Salah@chu-amiens.fr+33322088385

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026